Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Virology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • COVID-19 Special Collection
    • Minireviews
    • JVI Classic Spotlights
    • Archive
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JVI
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Transformation and Oncogenesis

Human T-Cell Leukemia Virus Type 1 Tax Enhances Serum Response Factor DNA Binding and Alters Site Selection

Heather Y. Winter, Susan J. Marriott
Heather Y. Winter
Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Susan J. Marriott
Department of Molecular Virology and Microbiology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: susanm@bcm.tmc.edu
DOI: 10.1128/JVI.02179-06
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

Human T-cell leukemia virus type I (HTLV-1) is the etiological agent of adult T-cell leukemia. The viral transforming protein Tax regulates the transcription of viral and cellular genes by interacting with cellular transcription factors and coactivators. The effects of Tax on cellular gene expression have an important impact on HTLV-1-mediated cellular transformation. Expression of the c-fos cellular oncogene is regulated by serum response factor (SRF), and Tax is known to induce c-fos gene expression by activating SRF-responsive transcription. SRF activates cellular gene expression by binding to a consensus DNA sequence (CArG box) located within a serum response element (SRE). Since SRF activates transcription of many growth regulatory genes, this pathway is likely to have a significant impact on Tax-mediated transformation. Here we demonstrate that Tax interacts with SRF and enhances the binding of SRF to SREs located in the c-fos, Nur77, and viral promoters. Also, we establish that in the presence of Tax, SRF selects more divergent CArG box sequences than in the absence of Tax, revealing a novel mechanism for regulating SRF-responsive gene expression. Finally, increased association of SRF with chromatin and specific promoters was observed in Tax-expressing cells, correlating with increased c-fos and Nur77 mRNA levels in Tax-expressing cells. These results suggest that Tax activates SRF-responsive transcription by enhancing its binding affinity to multiple different SRE sequences.

The retrovirus human T-cell leukemia virus type 1 (HTLV-1) is the etiological agent of adult T-cell leukemia and the neurodegenerative disorder tropical spastic paraparesis/HTLV-1-associated myelopathy (60). Tax, the viral transforming protein, regulates viral and cellular gene expression at the transcriptional level. Although Tax does not bind DNA directly, a multitude of cellular genes are activated by Tax. Three major transcription factor pathways, CREB, NF-κB, and serum response factor (SRF), are activated by Tax. Since many of the genes regulated by these pathways are involved in cell cycle regulation, apoptosis, and DNA damage responses, it has long been believed that their dysregulation by Tax contributes to cellular transformation. Studies supporting this hypothesis have demonstrated that Tax-expressing cells have defects in the control of cell cycle progression, apoptosis, and DNA damage responses (25).

Tax has been shown to interact with CREB, which results in enhancement of DNA binding affinity, influence on site selection, and recruitment of the coactivators CBP, p300, and P/CAF to promoters, thereby activating transcription. In the presence of Tax, an increased binding affinity of CREB to the viral promoter has been observed (16, 18, 61). Additionally, in the presence of Tax, CREB prefers to bind sequences having G/C-rich flanking sequences that resemble elements in the viral promoter (41). Tax has also been shown to allow recruitment of coactivators to CREB-responsive elements in the absence of CREB phosphorylation (30).

Activation of the NF-κB pathway by Tax appears to occur through two mechanisms. Tax inactivates IκB in the cytoplasm by targeting it for proteasomal degradation, which releases the transcriptionally active form of NF-κB containing the p65 and p50 subunits and allows it to translocate to the nucleus (27, 53). Tax has also been shown to directly bind to the p65 and p50 subunits of NF-κB and recruit coactivators (5, 52, 54).

The SRF pathway remains the least characterized of the three major Tax activation pathways. Tax activates the c-fos, Egr-1, Egr-2, Fra-1, c-Jun, and JunD genes, each of which contain SRF binding sites in their promoters, suggesting that Tax regulates SRF-responsive transcription (1, 2, 20, 21, 40). Characterization of the promoters of these genes in transient-transfection assays demonstrated that Tax responsiveness mapped to the SRE (1, 2, 21, 22). In vivo and in vitro binding assays have demonstrated that the Tax and SRF interaction is mediated through amino acids 422 to 435 of SRF (19, 23, 52). Thus, Tax activation of SRF-responsive transcription may be mechanistically similar to Tax activation of CREB-regulated transcription in that the interaction of Tax with SRF may increase affinity of SRF for DNA and alter the sequence specificity of SRF binding. Since many growth regulatory genes are transcriptionally responsive to SRF, Tax activation of the SRF pathway may inappropriately regulate cell growth, thereby contributing to cellular transformation.

SRF, a member of the MADS domain family of transcription factors, functions to stimulate cell cycle entry in response to a variety of mitogenic signals. SRF activates the expression of immediate-early genes, including c-fos, fosB, junB, c-egr, Nur77, and Nurr1 (11, 31, 43, 47, 55, 57). In addition to being a well-studied immediate-early gene, c-fos is also a potent cellular oncogene (26). Increased c-fos gene and protein expression levels are detected in many human cancers as well as in animal cancer models (37). Therefore, the dysregulation of c-fos and other immediate-early genes by Tax may provide early oncogenic signals in HTLV-1-infected cells.

The nucleotide sequence CC(A/T)6GG, termed the CArG box, is the consensus DNA binding site for SRF (38). Immediate-early promoters contain a CArG box and frequently contain an adjacent Ets element that binds a member of the ternary complex transcription factor family (TCF) (28). Adjacent SRF and TCF Ets binding sites comprise a serum response element (SRE). Together, SRF and TCFs cooperatively activate transcription of immediate-early promoters through formation of a ternary complex on the SRE (49). Tax has been shown to interact with the TCF proteins Elk-1 and SAP-1, and the TCF binding sites in the c-fos SRE are required for full activation of this element by Tax (50). Therefore, it is possible that both SRF and the TCFs are targets for transcriptional deregulation of immediate-early promoters by Tax.

We previously showed that the HTLV-1 promoter contains a CArG box (vCArG) located within a putative SRE (vSRE) (58). The vSRE is located within a region of the viral promoter known as Tax responsive element 2 (TRE2). Other transcription factors that are known to bind this element include Sp-1, TIF-1, Ets1, and Myb (59). The viral promoter also contains three 21-bp imperfect repeats, which are individually known as Tax responsive element 1 (TRE1s) (8, 24, 42). CREB and other bZIP family members are known to bind the TRE1s and recruit Tax to activate transcription. Therefore, the transcriptional regulation of the viral promoter is mediated through a multitude of transcription factors.

The vCArG box was initially characterized in the absence of Tax, leaving the role of Tax in SRF-responsive transactivation of the viral long terminal repeat (LTR) to be determined. In addition, SREs of the c-fos, Egr-1, Egr-2, Fra-1, c-Jun, and JunD promoters are known to be Tax responsive in transient-transfection assays (1, 2, 21, 22). However, little is known about the mechanism by which Tax activates SRF-responsive transcription beyond the notion that Tax and SRF interact. Therefore, we hypothesized that Tax activation of SRF transcription involves a interaction of Tax with SRF that results in increased DNA binding affinity of SRF and alterations of preferred target DNA binding sites of SRF.

Here we show that Tax enhances the binding of SRF to its DNA binding sequence and that SRF selects more divergent binding sequences in the presence of Tax than in the absence of Tax. We also demonstrate that in cells the association of SRF with DNA is globally increased in the presence of Tax and that more SRF is bound to the c-fos promoter in Tax-expressing cells than in cells without Tax expression. These results suggest that Tax activates SRF-responsive transcription by interacting directly with SRF, leading to enhanced binding of SRF to many divergent CArG box DNA sequences.

MATERIALS AND METHODS

Recombinant protein purification.Tax protein was purified as previously described (34). Briefly, Escherichia coli cells transformed with the pX5 plasmid encoding Tax were pelleted, sonicated, centrifuged to remove insoluble material, and precipitated sequentially with ammonium sulfate. Glutathione S-transferase (GST-SRF) (13) was purified according to the manufacturer's protocol (Amersham GE Healthcare). Briefly, GST-SRF fusion protein was expressed in E. coli, bacterial pellets were lysed in 100 mM Tris-HCl, pH 7.5, 200 mM KCl, 10 mM dithiothreitol, 10 mM MgCl2, and then GST-SRF protein was purified in batch using glutathione beads. GST-SRF protein was eluted with glutathione elution buffer (25 mM reduced glutathione, 150 mM KCl, 50 mM Tris-HCl, pH 8.0).

Cell lines.Jurkat, CEM, C81-66 (48), and HuT102 (45) cell lines were all maintained in RPMI medium supplemented with 10% fetal bovine serum. MS-9 cells (51), provided by David Derse (National Cancer Institute, Fredrick, MD), were maintained as others with the addition of 100 U/ml interleukin-2 (NCI Preclinical Repository).

GST pull down.Purified Tax and GST-SRF proteins were tumbled with glutathione beads for 1 h. Beads were washed five times, and complexes were separated by 8% sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. SRF was detected by Western blotting using an SRF-specific antibody (sc-335; Santa Cruz Biotechnology). Tax was detected using polyclonal rabbit anti-Tax serum.

Plasmids and oligonucleotides.The sequences of the c-fos, Nur77, and viral SRE sense-strand oligonucleotides used in gel shift assays were 5′-GATCAGATCCAGGATGTCCATATTAGGACATCTGT-3′, 5′-GATCCCGCCGGAACCGCGCCGCCCCCCGCGCCCTTGTATGGCCAAAC-3′, and 5′-GATCCGGAGACCTCCGGGAAGCCACCGGAACCACCCATTTCCTCCCCATGTTTGTCAAGCC-3′, respectively. The primers used to amplify the c-fos promoter in chromatin immunoprecipitation (ChIP) assays were 5′-ACCCTCGGTGTTGGCTG-3′ and 5′-TCCTAATCTCGTGAGCATTTCG-3′. The 5′ and 3′ PCR primers used to amplify the c-fos cDNA were 5′-TCGGGCTTCAACGCAGACTACG-3′ and 5′-TGACCGTGGGAATGAAGTTGGC-3′, respectively. Amplification of the Nur77 cDNA used the 5′ and 3′ primers 5′-TTGGCACCCACTTCTCCACACC-3′ and 5′-GCACTGTGCGCTTGAAGAAGCC-3′, respectively.

EMSAs.Double-stranded oligonucleotides were labeled with [α-32P]dCTP using Klenow enzyme (New England Biolabs). Electrophoretic mobility shift assays (EMSAs) using purified proteins included 1× EMSA buffer (20 mM HEPES, pH 7.4, 100 mM KCl, 0.5 mM EDTA, 1 mM dithiothreitol, 0.1 mM phenylmethylsulfonyl fluoride, 10% glycerol), 1 μg sheared salmon sperm DNA (Sigma), 0.02 μg to 1 μg SRF, 2 μg Tax, and 0.5 nM labeled probe in a 20-μl total reaction volume. These reactions were incubated at room temperature for 20 to 30 min. Complexes were resolved on a 4% nondenaturing polyacrylamide gel in 0.6× Tris-borate-EDTA. Antibodies (2 μg per 20-μl reaction mixture) used in supershift EMSA experiments (anti-SRF [sc-335; Santa Cruz Biotechnology], monoclonal antibody Tab170 specific for Tax [NIH AIDS Research and Reference Reagent Program], and anti-AP-2 [Santa Cruz Biotechnology SC25343]) were added 15 min after initiating the protein and DNA incubation. Reaction mixtures were incubated at room temperature for 30 min after adding antibody.

SELEX.Specific SRF binding sequences were selected as previously described (46). Briefly, 1 μg of purified SRF alone, or together with 2 μg of Tax, was incubated with 0.4 ng of 32P-labeled randomized oligonucleotide (5′-GTCAGGATCCGTTCAGCTGTCG(N)16GAGGCAGTGCAATCTAGACTGC-3′), 50 μg/ml bovine serum albumin, and 200 ng of poly(dI-dC) for 30 min on ice. The complexes were then incubated with protein A beads (Upstate Biotechnology) that had been prebound with SRF-specific antibody (sc-335; Santa Cruz), or Tax-specific monoclonal antibody (Tab170; NIH AIDS Research and Reference Reagent Program) overnight with tumbling at 4°C. After washing three times with wash buffer (20 mM HEPES pH 7.9, 100 mM KCl, 0.2 mM EDTA, 0.2 mM EGTA, and 20% glycerol), DNA was eluted in 200 μl of recovery buffer (50 mM Tris-HCl pH 8.0, 100 mM sodium acetate, 5 mM EDTA, and 0.5% SDS) for 1 h at 45°C, phenol extracted, chloroform extracted, and then ethanol precipitated. Recovered probe was measured by Cerenkov counting in a scintillation counter, and 1 pg of recovered probe (compared to 1 pg of original systemic evolution of ligands by exponential enrichment [SELEX] input) was amplified by PCR using the primers 5′-GTCAGGATCCGTTCAGCTGTCG-3′ and 5′-GCAGTCTAGATTGCACTGCCTC-3′. The PCR products were purified from an 8% nondenaturing polyacrylamide gel. The amount of purified DNA was determined by Cerenkov counting using 1 pg of input DNA for comparison. The selection process was repeated for a total of five rounds. Selected DNA was blunt end cloned into pBlueScriptII (Stratagene) for sequencing. The ability of selected probes to bind SRF was verified by EMSA for each round of selection.

Chromatin isolation.Chromatin was isolated as previously described (36) with minor modifications. Briefly, 2.5 × 106 cells were pelleted, washed two times with phosphate-buffered saline, resuspended in 1 ml buffer A (10 mM HEPES pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M sucrose, 10% glycerol, and a Complete Mini EDTA-free protease inhibitor tablet [Roche]), Triton X-100 was added to 0.1%, and cells were incubated for 5 min on ice. Nuclei were collected by low-speed centrifugation, washed with buffer A, and pelleted as before. Pelleted nuclei were lysed in 200 μl buffer B (3 mM EDTA, 0.2 mM EGTA, and a Complete Mini EDTA-free protease inhibitor tablet [Roche]) for 30 min on ice. The insoluble chromatin fraction was collected by low-speed centrifugation and washed once in buffer B. The final chromatin pellet was resuspended in SDS loading dye and sonicated for 15 seconds. Samples were separated by 8% SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose for Western blotting. An antibody specific for ORC2 (BD Pharmingen) was used as a chromatin marker to distinguish the insoluble chromatin fraction from the soluble nuclear fraction.

ChIPs.ChIP assays were performed as previously described (58). Briefly, lysates from 5 × 107 Jurkat, C81-66, or HuT102 formaldehyde cross-linked cells were precleared with protein G beads (Upstate Biotechnology). Beads were prebound with an SRF-specific antibody (sc-335; Santa Cruz Biotechnology). Prebound beads were incubated with precleared lysates in immunoprecipitation (IP) buffer (20 mM Tris-HCl, pH 8.0, 150 mM NaCl, 2 mM EDTA, 1% Triton X-100, 1 μg/ml leupeptin, 1 μg/ml aprotinin, 1 μg/ml pepstatin, 1 mM phenylmethylsulfonyl fluoride) (9). Precipitated beads were washed sequentially with IP buffer once, IP buffer with 0.5 M NaCl twice, LiCl wash buffer (20 mM Tris-HCl, pH 8.0, 250 mM LiCl, 2 mM EDTA, 0.5% Nonidet P-40) twice, and Tris-EDTA once (6, 7, 9). Elution buffer (0.1 M NaHCO3, 1% SDS, 0.5 M NaCl) was added to the precipitated DNA-protein complexes, and the cross-links were reversed at 65°C overnight. Recovered DNA was analyzed by real-time PCR with primers specific for the c-fos promoter that spanned the SRF binding site.

mRNA isolation.mRNA was harvested using TRIzol reagent according to the manufacturer's protocol (Invitrogen). Briefly, 5 × 106 cells were pelleted and resuspended in 1 ml of TRIzol. RNA was recovered by chloroform extraction and ethanol precipitation. After DNase treatment, avian myeloblastosis virus reverse transcriptase (Invitrogen) was used to produce cDNA from 1 μg of mRNA.

Real-time PCR.Real-time PCR for cDNA analysis was performed using Platinum SYBER Green qPCR SuperMix-UDG (Invitrogen). Reaction mixtures containing 1× PCR Master Mix buffer, specific primers, and 0.1 μg of cDNA were amplified using a Roto-Gene real-time PCR machine (Corbett Research). Real-time PCR analysis of ChIP samples was performed using SYBR Green JumpStart Taq ReadyMix (Sigma) according to the manufacturer's protocol. ChIP data were analyzed using the following equation: (c-fosIP/c-fosinput)/(p53IP/p53input). All PCRs were performed in duplicate, and each experiment was repeated three times.

RESULTS

Tax and SRF interact.Previous studies demonstrated that Tax activates the expression of SRF-responsive genes and that Tax and SRF interact (23, 52). GST pull-down assays with recombinant purified Tax and GST-tagged SRF were used to confirm the direct interaction of Tax and SRF (Fig. 1A). Tax bound to SRF-loaded beads but not to beads in the absence of SRF. GST-SRF was observed as a doublet, which is likely due to a cleavage of the GST tag from SRF. The bottom band of the doublet ran near the expected size of the SRF protein (62 kDa), while the top band ran near the expected size of the fusion protein (90 kDa).

FIG. 1.
  • Open in new tab
  • Download powerpoint
FIG. 1.

Direct interaction of Tax and SRF. Western blots for SRF (top) and Tax (bottom) from GST pull-down assays. Controls include beads incubated with GST-SRF alone (lane 2), beads with Tax alone (lane 3), and beads only (lane 4).

If the interaction of Tax with SRF is important for activation of SRF-responsive genes, the SRF-Tax complex must be recruited to DNA. To determine whether Tax and SRF form a complex on DNA, SRE probes containing SRF binding sites from three different promoters (Fig. 2A) were used in supershift analyses. The c-fos SRE contains a canonical CArG box with the sequence CC(A/T)6GG. We recently established that SRF binds to a noncanonical CArG box (vSRE) that resides within Tax-responsive region 2 of the HTLV-1 LTR (58). The vSRE is 80% identical to a canonical SRE, with a G in the A/T-rich region and a T in the final G position. Since the Nur77 promoter contains a functional CArG box with 90% identity to the c-fos CArG box sequence and has the same G mismatch that exists in the A/T-rich region of the viral SRE, the Nur77 promoter SRE was also used as a probe.

FIG. 2.
  • Open in new tab
  • Download powerpoint
FIG. 2.

Tax and SRF form a complex on DNA. (A) Nucleotide sequences of the viral, c-fos, and Nur77 CArG boxes. The EMSA was conducted using 32P-labeled c-fos (B), Nur77 (C), or viral (D) SRE probes in the presence of GST-SRF alone (lane 3), Tax alone (lane 2), or GST-SRF and Tax (lane 4). Specific antibodies to Tax, SRF, and AP-2 (lanes 5, 6, and 7, respectively) were incubated with the indicated reaction mixtures. The location of supershifted bands is indicated on the right.

Incubation of GST-SRF with each of the labeled probes resulted in formation of a complex (Fig. 2B, C, and D, lane 3), while Tax alone did not form a complex with any of the labeled probes (Fig. 2B, C, and D, lane 2). If Tax could interact with SRF on DNA, we expected that the addition of Tax to the SRF gel shift reaction might reduce the mobility of the complex in the gel. Instead, incubation of Tax and SRF with the labeled probes produced complexes that migrated similar to the complex formed with SRF alone (Fig. 2B, C, and D, lane 4). However, addition of antibodies specific for Tax (lanes 5) or SRF (lane 6) further reduced the migration of the complex (Fig. 2B, C, and D), while a nonspecific antibody did not (Fig. 2B, C, and D, lane 7). Also, no shifted bands were detected when Tax- or SRF-specific antibodies were incubated with the probe alone (data not shown). These results suggest that Tax and SRF are both present in the complex. We also observed that the supershifted bands containing SRF antibody migrated more slowly than the supershifted bands containing Tax antibody. This is likely due to antibody differences, since the SRF antibody is purified rabbit immunoglobulin G while the Tax antibody is mouse ascites fluid.

Incubation of Tax and SRF together resulted in an increased intensity of the gel shift band (Fig. 2 B, C, and D, compare lanes 4 and 3). The increased intensity of the SRF-Tax complex was most readily observed when the c-fos and Nur77 SREs were used as probes. Therefore, we hypothesized that Tax enhances the binding of SRF to target DNA binding sites, specifically, cellular SREs.

Tax enhances the binding of SRF to DNA.Previous studies demonstrated that Tax can increase the affinity of cellular transcription factors, including ATF/CREB family members, Sp1, NF-κB, Fos-Jun heterodimer, and GAL4, for their target elements (3, 16, 18). In Fig. 2 we observed an increased intensity of the SRF complex in the presence of Tax and, thus, the ability of Tax to enhance the binding of SRF to various SREs was examined. Quantitative EMSAs were performed using the c-fos, Nur77, and viral SRE sequences described above. Increasing amounts of purified GST-SRF were incubated with each 32P-labeled probe alone or in the presence of a constant amount of purified Tax. Incubation of increasing SRF concentrations with the probe resulted in increased binding to all three sequences (Fig. 3 A, B, and C, lanes 2 through 8). However, intensity of the bands was noticeably reduced on vSRE, which varies from the canonical SRF binding site by 20%. In the presence of Tax, complexes were visible at lower SRF concentrations (Fig. 3 A, B, and C; for example, compare lanes 5 and 12). Since quantitation of these results demonstrated significantly more SRF bound to each element in the presence of Tax (Fig. 3 D, E, and F), we conclude that Tax enhances the binding of SRF to all three SREs. The ability of Tax to enhance the DNA binding affinity of SRF on all three probes suggests that even SREs that diverge from the canonical CArG box may be better utilized in the presence of Tax. Tax has been reported to enhance the binding affinity of other transcription factors, including ATF/CREB family members, Sp1, Fos-Jun heterodimer, and GAL4 (3, 16, 18). Thus, enhancement of transcription factor DNA binding affinity appears to be a common mechanism utilized by Tax to activate transcription, even when the target DNA sequence is nonconsensus.

FIG. 3.
  • Open in new tab
  • Download powerpoint
FIG. 3.

Tax enhances the binding of SRF to SREs. 32P-labeled c-fos (A), Nur77 (B), or viral (C) SRE probes were incubated with increasing amounts of GST-SRF alone (lanes 2 thru 8) or increasing GST-SRF with a constant amount of Tax (lanes 9 thru 15). Samples were analyzed by EMSA (left) and quantitated by phosphorimaging (right). Error bars represent the standard deviations from three independent experiments.

SRF tolerates more divergent sequences in the presence of Tax.The ability of Tax to enhance SRF binding affinity appeared to depend on the sequence of the DNA target site, prompting us to determine whether Tax could influence the target DNA sequence to which SRF binds. The SELEX method was used to identify DNA binding sequences preferred by SRF in the absence or presence of Tax. SRF was incubated alone, or in the presence of Tax, with a double-stranded 60-mer selection oligonucleotide containing 16 central randomized nucleotides flanked by 22 bp of defined sequence that were used for PCR amplification. DNA-protein complexes were allowed to form on this oligonucleotide, and the complexes were then immunoprecipitated with antibodies specific to either SRF or Tax. Precipitated DNA was eluted from the beads and amplified by PCR using primers specific for the conserved ends of the randomized selection oligonucleotide. The PCR product was subjected to another round of selection until five sequential rounds of selection had been performed. To ensure that sequences selected by the Tax:SRF complex bound SRF and Tax together and not SRF only, an antibody to Tax rather than SRF was used to retrieve the complexes.

Using this approach, a progressively greater portion of DNAs recovered after each round of selection should bind to SRF or Tax:SRF complexes. To test this prediction, DNA samples from each round of selection were analyzed by EMSA. SRF binding to sequences selected by GST-SRF alone was detected as early as round two (Fig. 4A, lane 8), increased slightly in round three, and remained relatively constant throughout subsequent rounds of selection. SRF binding to sequences selected by Tax and SRF were detected by round four and increased slightly after five rounds of selection (Fig. 4A, lanes 5 and 6). GST-SRF binding to DNAs selected in the negative control reactions was not observed in any round of SELEX (Fig. 4B).

FIG. 4.
  • Open in new tab
  • Download powerpoint
FIG. 4.

Enhanced SRF binding in later rounds of SELEX. (A) Enrichment of SRF binding sequences was examined by incubating GST-SRF with 32P-labeled input probe for the SELEX experiment (lane 1) or with DNA recovered from each round of SELEX using either GST-SRF plus Tax with a Tax-specific antibody (lanes 2 thru 6) or GST-SRF with an SRF-specific antibody (lanes 7 thru 11). The resulting samples were analyzed by EMSA. (B) As negative controls, recovered DNA from each round of SELEX was incubated with Tax alone, along with a Tax-specific antibody (lanes 1 thru 5) or GST-SRF plus Tax in the absence of antibody (lanes 6 thru 10). The resulting samples were analyzed by EMSA.

After five rounds of selection, the recovered DNAs were cloned and sequenced. The sequences from 54 clones resulting from the binding of SRF alone and 42 clones resulting from the binding of Tax and SRF were analyzed. Selected sequences were categorized based on their divergence from the consensus CArG box sequence (Table 1 and Fig. 5). Using an antibody to SRF in the presence of GST-SRF alone, 40 of the 54 sequenced clones (74.1%) corresponded to a consensus CArG box. Sequences similar to those selected by GST-SRF were also reported previously in a SELEX study of SRF (46). Since we showed that Tax and SRF associate cooperatively with SREs and that Tax does not bind to DNA specifically, an antibody to Tax was used to select Tax:SRF:DNA complexes. In contrast to SRF alone, when a Tax-specific antibody was used to recover Tax and GST-SRF complexes, only 17 of the 42 sequenced clones (40.5%) contained a consensus CArG box sequence. In the presence of SRF and Tax, more sequences (59.5%) diverged from the canonical CArG box than in the presence of SRF alone (25.9%). To ensure that sequences selected in reactions containing SRF and Tax did not result from nonspecific Tax binding directly to DNA, we sequenced DNAs recovered from negative control reactions that included Tax alone. No DNAs capable of forming gel shift complexes with SRF were detected in these Tax-selected reactions (Fig. 4B), and DNA sequencing failed to identify CArG box sequences in theses samples (data not shown). CArG box sequences were also not detected in a second negative control reaction containing GST-SRF and Tax in the absence of a specific antibody (data not shown). These results demonstrate that in the presence of Tax, SRF can bind more divergent CArG box sequences than the absence of Tax.

FIG. 5.
  • Open in new tab
  • Download powerpoint
FIG. 5.

Tax affects SRF binding site selection. Sequences for each selected CArG box category are represented as percentages of the total sequences analyzed for SRF only (white bars) or SRF plus Tax (gray bars). Error bars represent confidence intervals.

View this table:
  • View inline
  • View popup
TABLE 1.

Selected sequences from the fifth round of SELEX

Tax recruits SRF to chromatin in cells.The ability of Tax to promote SRF binding to divergent DNA sequences suggested that SRF would be recruited to an expanded set of cellular promoters in Tax-expressing cells. We tested this prediction by asking whether more SRF was associated with chromatin in Tax-expressing cells than in non-Tax-expressing cells. The insoluble chromatin fractions from Tax-negative cells (CEM) and Tax-positive cells (HuT102 and MS9) were collected and analyzed by Western blotting. Both of the Tax-positive cell lines tested contained higher levels of SRF in the chromatin fraction than did the Tax-negative cell line (Fig. 6A). The absence of chromatin contamination in the soluble fraction of the nuclear lysate was demonstrated by probing the blot with an antibody against origin of replication complex 2 (ORC2), which is known to be associated with chromatin (36) (Fig. 6B). As a control, Western blot assays for total SRF protein expression and actin as a loading control from the three cell lines were performed (Fig. 6C and D). These results demonstrated that more SRF is associated with chromatin in Tax-expressing cells, which is likely due to SRF recruitment to an expanded promoter set.

FIG. 6.
  • Open in new tab
  • Download powerpoint
FIG. 6.

Tax recruits SRF to chromatin. The chromatin fraction (lanes 1 thru 3) or soluble nuclear fraction (lanes 4 thru 6) of HTLV-1-negative cells (CEM) and HTLV-1-positive cells (HuT 102 and MS9) was analyzed by Western blotting for SRF (A) or for ORC2 (B). Whole-cell extracts were analyzed for total SRF (C) and actin (D) expression from CEM (lane 1), HuT 102 (lane 2), and MS9 (lane 3) cells.

Tax recruits SRF to specific promoters.To determine whether the increased association of SRF with chromatin in Tax-expressing cells could be observed on a promoter specifically responsive to SRF and Tax, we performed ChIP assays using an SRF-specific antibody and extracts from Jurkat cells (Tax negative) and C81-66 and HuT102 cells (Tax positive). After eluting the DNA precipitated from each cell line, the relative amount of c-fos promoter recovered in each ChIP was determined by real-time PCR (Fig. 7A). Quantitation was performed by normalizing the amount of c-fos promoter in the immunoprecipitated and input samples from each cell line to the amount of p53 promoter in the same samples. The p53 promoter does not contain an SRF binding site and therefore was used as the normalization standard in each experiment. Three independent experiments were performed, and the corrected amount of c-fos promoter precipitated from Jurkat cell extracts was set to 1 in each experiment (Fig. 7A). The corrected amount of c-fos promoter from each Tax-expressing cell line was normalized to Jurkat cells (Fig. 7A). The amount of c-fos promoter precipitated from Tax-expressing cells was sixfold higher than from Tax-negative cells. The Western blot assays in Fig. 7B and C demonstrate that the three cell lines express similar levels of SRF. Therefore, these results are consistent with our earlier in vitro EMSA findings, indicating that Tax increases the binding affinity of SRF to cellular promoters and providing further in vivo relevance that more SRF binds the c-fos promoter in Tax-expressing cells.

FIG. 7.
  • Open in new tab
  • Download powerpoint
FIG. 7.

Tax recruits SRF to specific promoters. (A) Relative levels of c-fos promoter precipitated from an SRF chromatin immunoprecipitation of HTLV-1-infected C81 and HuT 102 cells (gray bars) or uninfected Jurkat cells (white bar). The data were analyzed using the equation (c-fosIP/c-fosINPUT)/(p53IP/p53INPUT). (B) Western blots of whole-cell extracts from Jurkat, C81, and HuT 102 cells (lanes 1 to 3, respectively) were analyzed for total SRF expression. (C) As a loading control, blots from panel B were analyzed for actin expression.

Tax activates cellular SRF-responsive genes.The ability of Tax to interact with SRF and increase the affinity of SRF binding to promoters such as c-fos and Nur77 suggests that Tax can activate the expression of these genes. Tax has previously been shown to activate the c-fos promoter using transient-transfection assays, but the effects of Tax on the Nur77 promoter have not been previously reported. To determine whether the ability of Tax to enhance SRF binding and increase the diversity of SRF binding sites had functional effects on Tax transactivation, expression of the endogenous c-fos and Nur77 genes was examined in Tax-expressing and nonexpressing cells (Fig. 8). Real-time PCR was used to quantitate c-fos and Nur77 mRNA levels in Tax-expressing cells (HuT102 and MS9) and in non-Tax-expressing cells (Jurkat and CEM). Glyceraldehyde-3-phosphate dehydrogenase expression was determined from each RNA sample and used to normalize relative gene expression between cell lines. Expression of the c-fos and Nur77 transcripts was greater in Tax-expressing lymphocytes than in non-Tax-expressing lymphocytes, suggesting that Tax is a potent activator of these cellular genes.

FIG. 8.
  • Open in new tab
  • Download powerpoint
FIG. 8.

Tax activates c-fos and Nur77 RNA expression. Relative levels of c-fos (A) and Nur77 (B) mRNA in Tax-positive (HuT 102 and MS9) and Tax-negative (Jurkat and CEM) cell lines were analyzed by real-time PCR. Each graph represents three independent experiments. RNA levels of each gene in Jurkat cells were set to 1. *, Student t tests showed a significant difference between each Tax-positive and Tax-negative cell line individually, all with P values of <0.05.

DISCUSSION

This study provides new insight into the mechanism of Tax activation of SRF-responsive transcription by demonstrating that Tax affects SRF binding affinity and DNA site selection. These results may explain the selective activation of SRF-responsive cellular genes by Tax. DNA binding data combined with the results of SELEX studies suggest that Tax activates SRF-responsive transcription by enhancing the binding of SRF to preferred DNA binding sequences. Tax activation of CREB-dependent promoters appears to involve a similar mechanism, with Tax enhancing the binding affinity of CREB and influencing CREB binding site selection and recruitment of cofactors. Although the crystal structure of CREB bound to DNA in the presence of Tax has not been solved, it has been suggested that Tax can alter CREB conformation and contact DNA bases flanking the CREB binding site, both of which may affect binding affinity and site selection (14, 32). Our results suggest that Tax activates SRF-responsive promoters through a similar mechanism, although further studies will be needed to elucidate the role of cofactors and potential SRF conformational changes in Tax activation of SRF-responsive promoters.

Since Tax has been shown to interact with TCF proteins and enhance transcription through these factors (50), it would therefore be interesting to further dissect the interplay between Tax, SRF, and TCFs. The same authors also demonstrated that activation of the c-fos SRE required the ability of Tax to bind CBP and P/CAF, suggesting the recruitment of cofactors is important for activation of the c-fos SRE by Tax (50). Therefore, deregulation of immediate-early promoters by Tax is likely to involve a multistep process that includes the interactions with SRF, TCFs, and cofactors such as CBP/p300 and P/CAF.

When a SELEX was performed using CREB and Tax, it was demonstrated that in the presence of Tax CREB selected binding sites that contained G-C-rich flanking regions (41). This is in contrast to our SRF and Tax SELEX in that we did not see any patterns emerge in the flanking sequences but that Tax did allow SRF to select more divergent core sequences. It has been suggested that Tax enhances CREB binding by inducing a conformation change in CREB as well as Tax contacting the flanking G-C-rich DNA sequences to form a stable structure on DNA (14, 32). To date, the mechanism of SRF binding to selected sequences in the presence of Tax remains unknown. Further investigation into the conformational changes of SRF in the presence of Tax as well as the ability of Tax to interact with DNA are needed to better understand the differences between the SRF:Tax:DNA and CREB:Tax:DNA complexes.

Although c-fos is known to be upregulated by Tax through the SRF pathway, this is the first report that Tax activates Nur77 transcription in an SRF-responsive manner. Nur77 is an SRF-responsive immediate-early gene that has been implicated in regulation of apoptosis and cellular proliferation (33). Recently, Nur77 has been reported to play a role in resistance to apoptosis in the presence of increased NF-κB activity (17). This is a very intriguing observation, since Tax also activates NF-κB-dependent transcription and Tax-expressing cells have been shown to be resistant to apoptosis (10, 15, 29, 39, 56). It is therefore possible that the resistance of Tax-expressing cells to apoptosis may require the combined functions of NF-κB and Nur77.

In the presence of Tax, SRF recognizes more divergent DNA sequences, which results in a global increase in the association of SRF with chromatin. These activities may allow Tax to activate transcription of a broader set of genes than does SRF alone. Many SRF-responsive cellular genes are immediate-early genes, which are responsible for initiating cell division in response to mitogenic signals (12). If Tax activated these genes in the absence of such signals, dysregulation of the cell cycle could occur. Interestingly, Tax-expressing cells do display abnormal cell cycle progression (35).

Transcriptional activation by Tax has long been thought to be an important mechanism in cellular transformation of HTLV-1-infected cells. Accumulating evidence has demonstrated that Tax activates transcription through a common mechanism which involves interacting with transcription factors, enhancing DNA binding, influencing transcription factor site selection, and coactivator recruitment. Tax has previously been shown to enhance the DNA binding affinity of many different transcription factors and to alter the DNA binding site preference of CREB (3, 4, 41, 44). The current study demonstrates that Tax can enhance the DNA binding affinity of SRF and alter its preferred target site selection. It is likely that Tax influences the activity of many different cellular transcription factors due to enhanced binding and altered DNA site selection. Dysregulation of cellular transcription may upset the balance of important regulatory pathways and lead to inappropriate cell division, resistance to apoptosis, and inhibition of DNA repair all of which have been reported for Tax-expressing cells. These combined activities could contribute to the transforming properties of this viral oncoprotein.

ACKNOWLEDGMENTS

We thank David Derse for providing MS-9 cells, the NCI Biological Resources Branch for providing interleukin-2, the NIH AIDS Research and Reference Reagent Program for providing anti-Tax monoclonal antibodies, and members of the Marriott lab for helpful discussions and support. We also thank Diane Wycuff for her expertise and input during the initial stages of this work and Claudia Kozinetz for statistical advice.

These studies were supported by Public Health Service grants R01 CA55684 and R01 CA77371 awarded to S.J.M. from the National Cancer Institute. H.Y.W. was supported, in part, by NIH training grant T32 AI07471.

FOOTNOTES

    • Received 4 October 2006.
    • Accepted 16 March 2007.
  • Copyright © 2007 American Society for Microbiology

REFERENCES

  1. 1.↵
    Alexandre, C., P. Charnay, and B. Verrier. 1991. Transactivation of Krox-20 and Krox-24 promoters by the HTLV-I Tax protein through common regulatory elements. Oncogene6:1851-1857.
    OpenUrlPubMedWeb of Science
  2. 2.↵
    Alexandre, C., and B. Verrier. 1991. Four regulatory elements in the human c-fos promoter mediate transactivation by HTLV-I Tax protein. Oncogene6:543-551.
    OpenUrlPubMed
  3. 3.↵
    Armstrong, A. P., A. A. Franklin, M. N. Uittenbogaard, H. A. Giebler, and J. K. Nyborg. 1993. Pleiotropic effect of human T cell leukemia virus Tax protein on the DNA binding activity of eukaryotic transcription factors. Proc. Natl. Acad. Sci. USA90:7303-7307.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    Baranger, A. M., C. R. Palmer, M. K. Hamm, H. A. Giebler, A. Brauweiler, J. K. Nyborg, and A. Schepartz. 1995. Mechanism of DNA-binding enhancement by the human T-cell leukaemia virus transactivator Tax. Nature376:606-608.
    OpenUrlCrossRefPubMedWeb of Science
  5. 5.↵
    Bex, F., A. McDowall, A. Burny, and R. Gaynor. 1997. The human T-cell leukemia virus type 1 transactivator protein tax colocalizes in unique nuclear structures with NF-κB proteins. J. Virol.71:3484-3497.
    OpenUrlAbstract/FREE Full Text
  6. 6.↵
    Boyd, K. E., and P. J. Farnham. 1999. Coexamination of site-specific transcription factor binding and promoter activity in living cells. Mol. Cell. Biol.19:8393-8399.
    OpenUrlAbstract/FREE Full Text
  7. 7.↵
    Boyd, K. E., J. Wells, J. Gutman, S. M. Bartley, and P. J. Farnham. 1998. c-Myc target gene specificity is determined by a post-DNA-binding mechanism. Proc. Natl. Acad. Sci. USA95:13887-13892.
    OpenUrlAbstract/FREE Full Text
  8. 8.↵
    Brady, J. N., K.-T. Jeang, J. Duvall, and G. Khoury. 1987. Identification of p40x-responsive regulatory sequences within the human T-cell leukemia virus type I long terminal repeat. J. Virol.61:2175-2181.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    Braunstein, M., A. B. Rose, S. G. Holmes, C. D. Allis, and J. R. Broach. 1993. Transcriptional silencing in yeast is associated with reduced nucleosome acetylation. Genes Dev.7:592-604.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    Brauweiler, A., J. E. Garrus, J. C. Reed, and J. K. Nyborg. 1997. Repression of Bax gene expression by the HTLV-I Tax protein: implications for suppression of apoptosis in virally infected cells. Virology231:135-140.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    Castillo, S. O., Q. Xiao, M. S. Lyu, C. A. Kozak, and V. M. Nikodem. 1997. Organization, sequence, chromosomal localization, and promoter identification of the mouse orphan nuclear receptor Nurr1 gene. Genomics41:250-257.
    OpenUrlCrossRefPubMed
  12. 12.↵
    Cen, B., A. Selvaraj, and R. Prywes. 2004. Myocardin/MKL family of SRF coactivators: key regulators of immediate early and muscle specific gene expression. J. Cell Biochem.93:74-82.
    OpenUrlCrossRefPubMedWeb of Science
  13. 13.↵
    Chen, C. Y., and R. J. Schwartz. 1996. Recruitment of the tinman homolog Nkx-2.5 by serum response factor activates cardiac alpha-actin gene transcription. Mol. Cell. Biol.16:6372-6384.
    OpenUrlAbstract/FREE Full Text
  14. 14.↵
    Connor, L. C., and S. J. Marriott. 2000. Sequences flanking the cAMP responsive core of the HTLV-I Tax response elements influence CREB protease sensitivity. Virology270:328-336.
    OpenUrlCrossRefPubMed
  15. 15.↵
    Copeland, K. F. T., A. G. M. Haaksma, J. Goudsmit, P. H. Krammer, and J. L. Heeney. 1994. Inhibition of apoptosis in T cells expressing human T cell leukemia virus type I Tax. AIDS Res. Hum. Retrovir.10:1259-1268.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    Cox, J. M., L. S. Sloan, and A. Schepartz. 1995. Conformation of Tax-response elements in the human T-cell leukemia virus type I promoter. Chem. Biol.2:819-826.
    OpenUrlCrossRefPubMed
  17. 17.↵
    de Leseleuc, L., and F. Denis. 2006. Inhibition of apoptosis by Nur77 through NF-κB activity modulation. Cell Death Differ.13:293-300.
    OpenUrlCrossRefPubMed
  18. 18.↵
    Franklin, A. A., M. F. Kubik, M. N. Uittenbogaard, A. Brauweiler, P. Utaisincharoen, M.-A. H. Matthews, J. P. Hoeffler, and J. K. Nyborg. 1993. Transactivation by the human T-cell leukemia virus Tax protein is mediated through enhanced binding of ATF-2 and CREB. J. Biol. Chem.268:21225-21231.
    OpenUrlAbstract/FREE Full Text
  19. 19.↵
    Fujii, M., T. Chuhjo, T. Minamino, N. Masaaki, K. Miyamoto, and M. Seiki. 1995. Identification of the Tax interaction region of serum response factor that mediates the aberrant induction of immediate early genes through CArG boxes by HTLV-I Tax. Oncogene11:7-14.
    OpenUrlPubMedWeb of Science
  20. 20.↵
    Fujii, M., T. Niki, T. Mori, T. Matsuda, M. Matsui, N. Nomura, and M. Seiki. 1991. HTLV-I Tax induces expression of various immediate early serum responsive genes. Oncogene6:1023-1029.
    OpenUrlPubMedWeb of Science
  21. 21.↵
    Fujii, M., P. Sassone-Corsi, and I. M. Verma. 1988. c-Fos promoter transactivation by the tax1 protein of human T-cell leukemia virus type I. Proc. Natl. Acad. Sci. USA85:8526-8530.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    Fujii, M., H. Tsuchiya, T. Chuhjo, T. Akizawa, and M. Seiki. 1992. Interaction of HTLV-I Tax1 with p67SRF causes the aberrant induction of cellular immediate early genes through CArG boxes. Genes Dev.6:2066-2076.
    OpenUrlAbstract/FREE Full Text
  23. 23.↵
    Fujii, M., H. Tsuchiya, T. Chuhjo, T. Minamino, K.-I. Miyamoto, and M. Seiki. 1994. Serum response factor has functional roles both in indirect binding to the CArG box and in the transcriptional activation function of human T-cell leukemia virus type I Tax. J. Virol.68:7275-7283.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    Fujisawa, J.-I., M. Seiki, M. Sato, and M. Yoshida. 1986. A transcriptional enhancer sequence of HTLV-I is responsible for transactivation mediated by p40x of HTLV-I. EMBO J.5:713-718.
    OpenUrlPubMedWeb of Science
  25. 25.↵
    Gatza, M. L., J. C. Watt, and S. J. Marriott. 2003. Cellular transformation by the HTLV-I Tax protein, a jack-of-all-trades. Oncogene22:5141-5149.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    Greenberg, M. E., and E. B. Ziff. 1984. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene. Nature311:433-438.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    Hirai, H., T. Suzuki, J.-I. Fujisawa, J. Inoue, and M. Yoshida. 1994. Tax protein of human T-cell leukemia virus type I binds to the ankyrin motifs of inhibitory factor κB and induces nuclear translocation of transcription factor NF-κB proteins for transcriptional activation. Proc. Natl. Acad. Sci. USA91:3584-3588.
    OpenUrlAbstract/FREE Full Text
  28. 28.↵
    Johansen, F. E., and R. Prywes. 1994. Two pathways for serum regulation of the c-fos serum response element require specific sequence elements and a minimal domain of serum response factor. Mol. Cell. Biol.14:5920-5928.
    OpenUrlAbstract/FREE Full Text
  29. 29.↵
    Kishi, S., S. Saijyo, M. Arai, S. Karasawa, S. Ueda, M. Kannagi, Y. Iwakura, M. Fujii, and S. Yonehara. 1997. Resistance to Fas-mediated apoptosis of peripheral T cells in human T lymphocyte virus type I (HTLV-I) transgenic mice with autoimmune arthropathy. J. Exp. Med.186:57-64.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    Kwok, R. P. S., M. E. Laurance, J. R. Lundblad, P. S. Goldman, H. M. Shih, L. M. Connor, S. J. Marriott, and R. H. Goodman. 1996. Control of cAMP-regulated enhancers by the viral transactivator Tax through CREB and the co-activator CBP. Nature380:642-646.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    Lazo, P. S., K. Dorfman, T. Noguchi, M. G. Mattei, and R. Bravo. 1992. Structure and mapping of the fosB gene. FosB downregulates the activity of the fosB promoter. Nucleic Acids Res.20:343-350.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    Lenzmeier, B. A., H. A. Giebler, and J. K. Nyborg. 1998. Human T-cell leukemia virus type 1 Tax requires direct access to DNA for recruitment of CREB binding protein to the viral promoter. Mol. Cell. Biol.18:721-731.
    OpenUrlAbstract/FREE Full Text
  33. 33.↵
    Li, Q. X., N. Ke, R. Sundaram, and F. Wong-Staal. 2006. NR4A1, 2, 3—an orphan nuclear hormone receptor family involved in cell apoptosis and carcinogenesis. Histol. Histopathol.21:533-540.
    OpenUrlPubMedWeb of Science
  34. 34.↵
    Lindholm, P. F., S. J. Marriott, S. D. Gitlin, and J. N. Brady. 1990. Differential precipitation and zinc chelate chromatography purification of biologically active HTLV-I Tax1 expressed in E. coli. J. Biochem. Biophys. Methods22:233-241.
    OpenUrlCrossRef
  35. 35.↵
    Marriott, S. J., and O. J. Semmes. 2005. Impact of HTLV-I Tax on cell cycle progression and the cellular DNA damage repair response. Oncogene24:5986-5995.
    OpenUrlCrossRefPubMedWeb of Science
  36. 36.↵
    Mendez, J., and B. Stillman. 2000. Chromatin association of human origin recognition complex, cdc6, and minichromosome maintenance proteins during the cell cycle: assembly of prereplication complexes in late mitosis. Mol. Cell. Biol.20:8602-8612.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    Milde-Langosch, K. 2005. The Fos family of transcription factors and their role in tumourigenesis. Eur. J. Cancer41:2449-2461.
    OpenUrlCrossRefPubMedWeb of Science
  38. 38.↵
    Mohun, T., N. Garrett, and R. Treisman. 1987. Xenopus cytoskeletal actin and human c-fos gene promoters share a conserved protein-binding site. EMBO J.6:667-673.
    OpenUrlPubMedWeb of Science
  39. 39.↵
    Mulloy, J. C., T. Kislyakova, A. Cereseto, L. Casareto, A. LoMonico, J. Fullen, M. V. Lorenzi, A. Cara, C. Nicot, C. Z. Giam, and G. Franchini. 1998. Human T-cell lymphotropic/leukemia virus type 1 Tax abrogates p53-induced cell cycle arrest and apoptosis through its CREB/ATF functional domain. J. Virol.72:8852-8860.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    Nagata, K., M. Ohtani, M. Nakamura, and K. Sugimura. 1989. Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded by p40tax protein in the human T-cell line, Jurkat. J. Virol.63:3220-3226.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    Paca-Uccaralertkun, S., L.-J. Zhao, N. Adya, J. V. Cross, B. R. Cullen, I. M. Boros, and C.-Z. Giam. 1994. In vitro selection of DNA elements highly responsive to the human T-cell lymphotropic virus type I transcriptional activator, Tax. Mol. Cell. Biol.14:456-462.
    OpenUrlAbstract/FREE Full Text
  42. 42.↵
    Paskalis, H., B. K. Felber, and G. N. Pavlakis. 1986. cis-acting sequences responsible for the transcriptional activation of human T cell leukemia virus I constitute a conditional enhancer. Proc. Natl. Acad. Sci. USA83:6558-6563.
    OpenUrlAbstract/FREE Full Text
  43. 43.↵
    Perez-Albuerne, E. D., G. Schatteman, L. K. Sanders, and D. Nathans. 1993. Transcriptional regulatory elements downstream of the JunB gene. Proc. Natl. Acad. Sci. USA90:11960-11964.
    OpenUrlAbstract/FREE Full Text
  44. 44.↵
    Perini, G., S. Wagner, and M. R. Green. 1995. Recognition of bZIP proteins by the human T-cell leukaemia virus transactivator Tax. Nature376:602-605.
    OpenUrlCrossRefPubMedWeb of Science
  45. 45.↵
    Poiesz, B. J., F. W. Ruscetti, J. W. Mier, A. M. Woods, and R. C. Gallo. 1980. T-cell lines established from human T-lymphocytic neoplasias by direct response to T-cell growth factor. Proc. Natl. Acad. Sci. USA77:6815-6819.
    OpenUrlAbstract/FREE Full Text
  46. 46.↵
    Pollock, R., and R. Treisman. 1990. A sensitive method for the determination of protein-DNA binding specificities. Nucleic Acids Res.18:6197-6204.
    OpenUrlCrossRefPubMedWeb of Science
  47. 47.↵
    Qureshi, S. A., M. Rim, J. Bruder, W. Kolch, U. Rapp, V. P. Sukhatme, and D. A. Foster. 1991. An inhibitory mutant of c-Raf-1 blocks v-Src-induced activation of the Egr-1 promoter. J. Biol. Chem.266:20594-20597.
    OpenUrlAbstract/FREE Full Text
  48. 48.↵
    Salahuddin, S. Z., P. D. Markham, F. Wong-Staal, G. Franchini, V. S. Kalyanaraman, and R. C. Gallo. 1983. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes. Virology129:51-64.
    OpenUrlCrossRefPubMedWeb of Science
  49. 49.↵
    Shore, P., and A. D. Sharrocks. 1994. The transcription factors Elk-1 and serum response factor interact by direct protein-protein contacts mediated by a short region of Elk-1. Mol. Cell. Biol.14:3283-3291.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    Shuh, M., and D. Derse. 2000. Ternary complex factors and cofactors are essential for human T-cell leukemia virus type 1 tax transactivation of the serum response element. J. Virol.74:11394-11397.
    OpenUrlAbstract/FREE Full Text
  51. 51.↵
    Shuh, M., S. A. Hill, and D. Derse. 1999. Defective and wild-type human T-cell leukemia virus type I proviruses: characterization of gene products and trans-interactions between proviruses. Virology262:442-451.
    OpenUrlCrossRefPubMed
  52. 52.↵
    Suzuki, T., H. Hirai, J.-I. Fujisawa, T. Fujita, and M. Yoshida. 1993. A trans-activator Tax of human T-cell leukemia virus type 1 binds to NF-κB p50 and serum response factor (SRF) and associates with enhancer DNAs of the NF-κB site and CArG box. Oncogene8:2391-2397.
    OpenUrlPubMedWeb of Science
  53. 53.↵
    Suzuki, T., H. Hirai, T. Murakami, and M. Yoshida. 1995. Tax protein of HTLV-1 destabilizes the complexes of NF-κB and IκB-α and induces nuclear translocation of NF-κB for transcriptional activation. Oncogene10:1199-1207.
    OpenUrlPubMedWeb of Science
  54. 54.↵
    Suzuki, T., H. Hirai, and M. Yoshida. 1994. Tax protein of HTLV-1 interacts with the Rel homology domain of NF-κB p65 and c-Rel proteins bound to the NF-κB binding site and activates transcription. Oncogene9:3099-3105.
    OpenUrlPubMed
  55. 55.↵
    Treisman, R. 1986. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell46:567-574.
    OpenUrlCrossRefPubMedWeb of Science
  56. 56.↵
    Tsukahara, T., M. Kannagi, T. Ohashi, H. Kato, M. Arai, G. Nunez, Y. Iwanaga, N. Yamamoto, K. Ohtani, M. Nakamura, and M. Fujii. 1999. Induction of Bcl-xL expression by human T-cell leukemia virus type 1Tax through NF-kB in apoptosis-resistant T-cell transfectants with Tax. J. Virol.73:7981-7987.
    OpenUrlAbstract/FREE Full Text
  57. 57.↵
    Williams, G. T., and L. F. Lau. 1993. Activation of the inducible orphan receptor gene nur77 by serum growth factors: dissociation of immediate-early and delayed-early responses. Mol. Cell. Biol.13:6124-6136.
    OpenUrlAbstract/FREE Full Text
  58. 58.↵
    Wycuff, D. R., H. L. Yanites, and S. J. Marriott. 2004. Identification of a functional serum response element in the HTLV-I LTR. Virology324:540-553.
    OpenUrlCrossRefPubMed
  59. 59.↵
    Yanites, H. L., K. K. Woodard, and S. J. Marriott. 2003. Modular control of HTLV-I transcription: a story of cooperation and competition. Curr. Top. Virol.3:109-117.
    OpenUrl
  60. 60.↵
    Yoshida, M., I. Miyoshi, and Y. Hinuma. 1982. Isolation and characterization of retrovirus from cell lines of human adult T-cell leukemia and its importance in the disease. Proc. Natl. Acad. Sci. USA79:2031-2035.
    OpenUrlAbstract/FREE Full Text
  61. 61.↵
    Zhao, L. J., and C. Z. Giam. 1992. Human T-cell lymphotropic virus type I (HTLV-I) transcriptional activator, Tax, enhances CREB binding to HTLV-I 21 base pair repeats by protein-protein interaction. Proc. Natl. Acad. Sci. USA89:7070-7074.
    OpenUrlAbstract/FREE Full Text
PreviousNext
Back to top
Download PDF
Citation Tools
Human T-Cell Leukemia Virus Type 1 Tax Enhances Serum Response Factor DNA Binding and Alters Site Selection
Heather Y. Winter, Susan J. Marriott
Journal of Virology May 2007, 81 (11) 6089-6098; DOI: 10.1128/JVI.02179-06

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Virology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Human T-Cell Leukemia Virus Type 1 Tax Enhances Serum Response Factor DNA Binding and Alters Site Selection
(Your Name) has forwarded a page to you from Journal of Virology
(Your Name) thought you would be interested in this article in Journal of Virology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Human T-Cell Leukemia Virus Type 1 Tax Enhances Serum Response Factor DNA Binding and Alters Site Selection
Heather Y. Winter, Susan J. Marriott
Journal of Virology May 2007, 81 (11) 6089-6098; DOI: 10.1128/JVI.02179-06
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

KEYWORDS

DNA, Viral
Gene Expression Regulation, Viral
Gene Products, tax
Human T-lymphotropic virus 1
Serum Response Factor

Related Articles

Cited By...

About

  • About JVI
  • Editor in Chief
  • Editorial Board
  • Policies
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Ethics
  • Contact Us

Follow #Jvirology

@ASMicrobiology

       

 

JVI in collaboration with

American Society for Virology

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

 

American Society for Microbiology
1752 N St. NW
Washington, DC 20036
Phone: (202) 737-3600

Copyright © 2021 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0022-538X; Online ISSN: 1098-5514